Median ERBB2 expression was similar between primary and metastatic tumors (47 v 47 TPM, p = 0.95) but significantly higher in liver metastases (59 v 45 TPM, p < 0.001) (Figure 1A). Here, ERBB2 is linked to metastatic neoplasm.